Breast implants tied to rare cancer to remain on U.S. market

  • 📰 CBSHealth
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

Colombia Noticias Noticias

Colombia Últimas Noticias,Colombia Titulares

There have been more than 600 of these cancer cases worldwide, but the FDA decided against a ban

of breast implant-associated anaplastic large cell lymphoma after noticing a lump under her arm.

"I could feel a mass that was the size of an egg, it was an egg to a lemon [sized], it was very large," she told"CBS This Morning" in 2017. She learned it was cancer, possibly connected to the cosmetic breast implants she'd had put in 17 years ago. "I was never informed that I could possibly get cancer. Basically they said they're 100 percent safe," Rogers said.

Diana Zuckerman, who has studied breast implant safety, said a ban may not be necessary to phase out textured ones."I think a lot of physicians are going to avoid them and patients are going to say they don't want them," said Zuckerman, president of the nonprofit, National Center for Health Research, which evaluates studies and conducts its own research.Breast augmentation is the most popular form of cosmetic surgery in the U.S.

 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 480. in CO

Colombia Últimas Noticias, Colombia Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from marketAt US_FDA's request, Allergan is recalling all of its Biocell textured breast implants to protect women from the risk of breast implant–associated anaplastic large cell lymphoma.
Fuente: HHSGov - 🏆 147. / 63 Leer más »